What are the histopathological features of the urticarial stage of bullous pemphigoid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Histopathological Features of Urticarial Stage Bullous Pemphigoid

In the urticarial (pre-bullous) stage of bullous pemphigoid, histopathological findings are often nonspecific and may show only eosinophilic spongiosis, dermal infiltrate of eosinophils and/or neutrophils, or marginalization of eosinophils along the dermoepidermal junction—without the classic subepidermal blister formation. 1

Key Histopathologic Findings in Urticarial Stage

The European Dermatology Forum consensus guidelines explicitly state that "in the absence of blistering and in nonbullous forms, histopathological findings may be nonspecific, such as the presence of eosinophilic spongiosis." 1 This is critical because it explains why diagnosis during the urticarial phase is challenging on histology alone.

Specific Features to Expect:

  • Eosinophilic spongiosis (most characteristic nonspecific finding)
  • Dermal infiltrate containing eosinophils and/or neutrophils
  • Marginalization of eosinophils along the dermoepidermal junction
  • Absence of subepidermal bulla (which defines the later bullous stage)
  • Urticarial or eczematous changes on routine H&E staining 2

Clinical Context and Diagnostic Pitfalls

The urticarial stage can persist for weeks to months—or even years in some cases 3—before frank blistering develops. During this prodromal phase, patients present with:

  • Intensely pruritic urticarial lesions
  • Erythematous or eczematous eruptions
  • Excoriated papules
  • No visible blisters 4, 5, 6

Critical pitfall: Approximately 17% of bullous pemphigoid cases show only urticarial or eczematous findings on histology, and only 54% demonstrate the classic subepidermal clefting even when biopsied 2. This means histopathology alone cannot exclude bullous pemphigoid during the urticarial stage.

Essential Diagnostic Approach

Since histopathology is nonspecific in the urticarial stage, direct immunofluorescence (DIF) is absolutely essential and represents the most critical diagnostic test 1. The guidelines emphasize that DIF positivity is mandatory for diagnosis.

DIF Findings (from perilesional skin):

  • Linear deposits of IgG and/or C3 along the dermoepidermal junction (n-serrated pattern)
  • Occasionally IgA and IgE with similar pattern 1

Complementary Testing:

  • Serum anti-BP180 and/or anti-BP230 antibodies by ELISA 1
  • Indirect immunofluorescence on salt-split skin showing epidermal-side binding 1

Practical Recommendations

When biopsying suspected urticarial-stage BP:

  1. Take TWO biopsies simultaneously:

    • One from urticarial/erythematous skin in formalin for H&E (expect nonspecific findings)
    • One from perilesional skin in Michel's medium or saline for DIF (diagnostic)
  2. Do NOT rely on H&E alone during the urticarial phase—the findings are too nonspecific 1

  3. Maintain high clinical suspicion in elderly patients with persistent pruritic urticarial eruptions of unknown cause, even when initial biopsies show only eczematous or urticarial changes 5, 6, 3

  4. Consider repeat biopsy with DIF if clinical suspicion remains high despite initial nonspecific findings, as the disease may evolve over time 2, 3

The European guidelines make clear that proper diagnosis requires the combination of compatible clinical features, light microscopy findings (even if nonspecific), and positive DIF—with DIF being the non-negotiable requirement 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.